Cocrystal Pharma COCP
NASDAQ COCP
$1.16 +0.02 (+1.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cocrystal Pharma (COCP) Asset Writedowns and Impairment (2015 - 2022)

Updated

Cocrystal Pharma's Asset Writedowns and Impairment came in at $19.09 million for FY2022.

Analysis

Cocrystal Pharma (COCP) Asset Writedowns and Impairment (2015 - 2022) Analysis & Trends

Going back to FY2011, Cocrystal Pharma's Asset Writedowns and Impairment data covers 7 years.

  • Asset Writedowns and Impairment carries a four-year compound annual growth rate of -22.9% (FY2018 to FY2022).
  • The FY2022 figure represents the highest annual Asset Writedowns and Impairment since FY2019.
  • Per Business Quant, earlier years put Asset Writedowns and Impairment at $46.1 million in FY2019 (-14.5%) and $53.91 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Cocrystal Pharma 16.00 Mn -5.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 19.09 Mn
Dec 31, 2015 38.67 Bn
API Access

Cocrystal Pharma Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=COCP&period=max&api_key=YOUR_API_KEY